-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESBlog
HHS OIG Issues Special Fraud Alert on Industry Speaker Program Practice
Nov 24, 2020
COVID-19 has significantly impacted in-person HCP engagements in the life sciences industry. Many of these have been understood as temporary, to be resumed once the pandemic subsides.
In a newly published OIG Special Fraud Alert, the regulatory body is reaffirming their stance that in-person speaker events must be regulated and follow strict compliance guidelines. With this guidance, manufacturers should take this as a signal that there is heightened focus on this popular activity. Now is the time to review speaker bureau and speaker program activity to ensure that any gaps in existing controls are addressed.
IQVIA has been helping life sciences companies stay compliant for over 20 years. IQVIA stands alone in the industry with a dedicated practice tasked to constantly monitor, inform, and ultimately support our customers in their compliance needs related to HCP engagements, including live speaker programs.
IQVIA is the only partner that can provide full end to end HCP engagement management, reducing risk, and identifying compliance risk—while delivering meaningful and effective HCP engagements. IQVIA additionally provides the industry’s leading engagement management and transparency reporting software, along with the largest meeting services organization in the world.
IQVIA Global Compliance Consulting supports life sciences manufacturers, establishing a comprehensive compliance program with appropriate controls across governance, policies, processes, and operation monitoring. Specifically, around Speaker Programs, IQVIA supports the analysis of Speaker Bureau size, developing standards around annual planning, needs assessment and business justification. IQVIA helps life sciences organizations strengthen internal auditing and monitoring processes across various business functions, providing boots on the ground for in-person and virtual event monitoring, as well as data and transactional analysis.
IQVIA’s HCP Engagement Management solutions address many risk factors outlined in the OIG statement. Our out-of-the-box offerings enable embedded compliance, and business rules preconfigured to meet industry best practices and compliance guidelines.
The Chief Counsel to OIG, Gregory Demske, has alluded to the regulatory body’s increased concern over speaker programs in his remarks at the recent 21st Virtual Pharmaceutical and Medical Device Ethics and Compliance Congress.
The OIG Fraud Alert highlights key characteristics across recent investigations and settlements that indicate inappropriate intent, such as:- Significant passage of time with no new medical or scientific information nor a new FDA-approved or cleared indication for the speaker program with limited or no substantive information presented;
- Sponsoring a large number of programs on the same or substantially the same topic or product, especially in situations involving no recent substantive change in relevant information;
- Speaker program meals exceeding modest value and availability of alcohol – with greater concern if alcohol is free;
- Speaker program venues that are not conducive to educational discussions;
- HCP repeat attendance on the same or substantially the same topics, or a speaker’s attendance to a program that he or she has spoken on substantially the same topic;
- Attendees with no legitimate business reasons to attend the speaker program, including:
- Speaker’s or HCP attendee’s friends, significant others, family members
- Employees of HCPs of the speaker’s own medical practice
- Staff members for which the speaker is a medical director
- Any individuals with no use for the educational information;
- Commercial business units (sales and marketing) having influence over the selection of speakers or any selection criteria of speakers or attendees based on past or expected revenue that the HCPs had or will generate by prescribing or ordering the manufacturer’s products;
- HCP speakers compensated for more than Fair Market Value for their speaking services, or a compensation scheme that takes into account the volume or value of past or potential future business generated by individuals.
This Special Fraud Alert, the first of its type in the past six years, demonstrates the OIG’s spotlight on this topic and the regulatory body’s call to action to rethink current industry speaker program practices. Furthermore, OIG warns that all parties that participate in speaker programs are subject to scrutiny, further illustrating the skepticism of intent across all key players in current speaker program practices.
For more information on how IQVIA Commercial Compliance can help you navigate the current compliance landscape, visit our website or email us here.